Possible mechanisms of the formation of chronic fatigue syndrome in the clinical picture of multiple sclerosis

被引:17
作者
Kasatkin D.S. [1 ]
Spirin N.N. [1 ]
机构
[1] Yaroslavl State Medical Academy,
关键词
Chronicfatigue syndrome; Multiple sclerosis;
D O I
10.1007/s11055-007-0004-9
中图分类号
学科分类号
摘要
A frequent manifestation of multiple sclerosis (MS) is chronic fatigue syndrome, which can be defined as a subjective decrease in the level of physical and/or mental energy. Chronic fatigue syndrome can be divided into asthenia (fatigue at rest), pathological fatigability (fatigue on physical loading), and fatigue on the background of deterioration of other symptoms (exacerbation of MS). There are both central and peripheral mechanisms for the formation of fatigue. The combination of fatigue and affective disturbances, especially depression and sleep disorders (insomnia, restless legs syndrome) is common in MS and may provide evidence that they share common mechanisms - decreases in the activity of the serotoninergic and noradrenergic systems. An important component in the formation of chronic fatigue syndrome consists of endocrine and autoimmune factors, the latter having a greater effect on asthenia than on pathological fatigue. Further studies of the pathogenetic mechanisms of the formation of asthenia and pathological fatigue and clarification of their differential diagnostic signs should allow not only a better understanding of the nature of this syndrome, but also better selection of individual treatment. © Springer Science+Business Media, Inc. 2007.
引用
收藏
页码:215 / 219
页数:4
相关论文
共 74 条
[1]
Avedisova A.S., Kanaeva L.S., Ibragimov D.F., Lyupaeva N.V., Non-specific, psychological, and biological predictors of the efficacy of therapy with antidepressants in patients with depressive disorders (analytical review, part 2), Psikhiat. Psikhofarmakoter., 5, pp. 22-24, (2003)
[2]
Lantsova V.B., Askarova L.Sh., Sepp E.K., Zavalishin I.A., The role of acetylcholine receptors in the pathogenesis of autoimmune and neurodegenerative disorders of the nervous system, Neiroimmunologiya, 1, (2003)
[3]
Extrapyramidal Disorders: Handbook of Diagnosis and Treatment, (2002)
[4]
Afari N., Buchwald D., Chronic fatigue syndrome: A review, Amer. J. Psychiat., 160, pp. 221-236, (2003)
[5]
Afifi A.K., Bergman R.A., Functional Neuroanatomy, (1998)
[6]
Altemus M., Licino I., Iolkovsky L., Gold P.W., Stimulation of the hypothalamic-pituital-adrenal axis by bulimic behaviors, Amer. Psychiatr. Ass., (1992)
[7]
Bakshi R., Miletich R.S., Henschel K., Et al., Fatigue in multiple sclerosis: Cross-sectional correlation with brain MRI findings in 71 patients, Neurology, 53, pp. 1151-1155, (1999)
[8]
Bakshi R., Shaikh Z.A., Miletich R.S., Et al., Fatigue in multiple sclerosis and its relationship to depression and neurologic disability, Mult. Scler., 6, pp. 181-185, (2000)
[9]
Brod S.A., Marshall G.D., Henninger E.M., Et al., Interferon-beta 1b treatment decreases tumor necrosis factor-alpha and increases interleukin-6 production in multiple sclerosis, Neurology, 46, pp. 1633-1638, (1996)
[10]
Buchwald D., Wener M.H., Pearlman T., Et al., Markers of inflammation and immune activation in chronic fatigue and chronic fatigue syndrome, J. Rheumatol., 24, pp. 372-376, (1997)